Table 5.
Weeks | Dose groups (mg/kg body weight/day) |
|||||||
---|---|---|---|---|---|---|---|---|
Males (n = 10) |
Females (n = 10) |
|||||||
Control | 500 | 1000 | 2500 | Control | 500 | 1000 | 2500 | |
pH | 6.86 ± 0.05 | 6.84 ± 0.07 | 6.85 ± 0.10 | 6.84 ± 0.05 | 6.85 ± 0.05 | 6.95 ± 0.12 | 6.88 ± 0.10 | 6.79 ± 0.14 |
Total protein (g/g creatinine) | ||||||||
3.02 ± 1.51 | 3.39 ± 2.12 | 3.31 ± 1.70 | 3.67 ± 2.55 | 4.16 ± 2.11 | 4.14 ± 1.68 | 4.42 ± 1.00 | 4.03 ± 1.33 | |
Glucose (g/g creatinine) | ||||||||
0.18 ± 0.13 | 0.14 ± 0.07 | 0.24 ± 0.18 | 0.15 ± 0.06 | 0.08 ± 0.06 | 0.06 ± 0.05 | 0.09 ± 0.11 | 0.10 ± 0.05 |
All values represent the mean ± S.D. No significant differences were found between control and treated rats (P < 0.05, Dunnett’s test).